Mycosis fungoides: Review of epidemiological observations

Dermatology

Volumn 201, Issue 1, 2000, Pages 21-28

  Suárez Varela, M M Morales ^a,b   González, A Llopis ^a   Vila, A Marquina ^b   Bell, J ^c  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c Thames Cancer Registry   (United Kingdom)

Author keywords

Cutaneous T cell lymphoma; Epidemiology; Mycosis fungoides; Sezary syndrome

Indexed keywords

CARCINOGEN; NITROSAMINE;

ADULT; AGED; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; FEMALE; GENETIC PREDISPOSITION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SEZARY SYNDROME; SKIN LYMPHOMA; SKIN TUMOR; T CELL LYMPHOMA;

EID: 17544394801     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018423     Document Type: Review

References (46)

1. Lutzner MA, Edelson RL, Schein P, Green I, Kirkpatrick C, Ahmed A: Cutaneous T-cell lymphomas: The Sézary syndrome, MF and related disorders. Ann Intern Med 1975;83: 534-552.
2. Smith NP: Histologie criteria for early diagnosis of cutaneous T-cell lymphoma. Dermatol Clin 1994;12:315-322.
3. Shapiro PE, Pinto FJ: The histologic spectrum of mycosis fungoides Sézary syndrome (cutaneous T-cell lymphoma). Am J Surg Pathol 1994;18:645-667.
4. Willemze R, Kerl H. Sterry W, Berti E, Cerroni L, Chimenti S, Díaz-Pérez JL, Geerts ML, Goos M, Knobler R, Ralfiaer E, Santucci M, Smith N, Wechsler J, van Cloten WA, Meijer CJLM: EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-371.
5. Chuang TY, Su WP, Müller SA: Incidence of cutaneous T-cell lymphoma and other rare skin cancers in a defined population. J Am Acad Dermatol 1990;23:254-256.
6. Weinstock MA, Horm JW: Mycosis fungoides in the United States. JAMA 1988;60:42-46.
7. Kuzel TM, Roenigk HH Jr, Rosen ST: Mycosis fungoides and the Sézary syndrome: A review of pathogenesis, diagnosis and therapy. J Clin Oncol 1991;9:1298-1313.
8. Hoppe RT, Wood GS, Abel EA: Mycosis fungoides and the Sézary syndrome: Pathology, Staging, and treatment. Curr Probl Cancer 1990;14:293-371.
9. Diamadidou E, Cohen PR, Kurzrock R: Mycosis fungoides and Sézary syndrome. Blood 1996;88:2385-2409.
10. Weinstock MA: Epidemiology of mycosis fungoides. Semin Dcrmatol 1994;13:154-159.
11. Alibert JLM: Description des maladies de la peau observées à l'Hôpital St-Louis, Paris, Barrois L'aire et Fils, 1806, pp 413-416.
12. Bazin PAE: Maladies de la peau observées à l'Hôpital St-Louis, Paris, 1876.
13. Cohen SR, Stenn KS, Bravermann IM, Beck GJ: Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer 1980;46:2654-2666.
14. Wolfe JD, Trevor ED, Kjeldsberg CR: Pulmonary manifestations of mycosis fungoides. Cancer 1980;46:46:2648-2653.
15. Rappaport H, Thomas LB: Mycosis fungoides: the pathology of extracutaneous involvement. Cancer 1974;34:1198-1229.
16. Burg G, Dummer R, Nestle FO, Doebbeling U, Haeffner A: Cutaneous lymphomas consist of a spectrum of nosologically different entities including MF and small-plaque parapsoriasis. Arch Dermatol 1996;132:567-572.
17. King Ismael D, Bernard Ackermann A: Gutlate parapsoriasis/digitate dermatosis (small-plaque parapsoriasis) is mycosis fungoides. Am J Dermatopathol 1992;14:518-530.
18. Burns MK, Ellis CN, Cooper KD: Mycosis fungoides-type cutaneus T-cell lymphoma arising before 30 years of age: Immunophenotypic, immunogenotypic and clinicopathologic analysis of nine cases. J Am Acad Dermatol 1992;27: 974-978.
19. Rijlaarsdom U, Scheffer E, Meijer CJ, Kruyswijk MR, Willemze R: Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. J Am Acad Dermatol 1991; 24:216-220.
20. Greene M H, Dalager NA, Lamberg SI, Argyropoulos CE. Fraumeni JF Jr: Mycosis fungoides: Epidemiologie observations. Cancer Treat Rep 1979;63:597-606.
21. Bernstein L, Deapen D, Ross RK: Mycosis fungoides. JAMA 1989;261:1882.
22. Garzon MC: Cutaneous T cell lymphoma in children. Semin Cutan Med Surg 1999;18:226-232.
23. Quaglino P, Zaccagna A, Verrone A, Dardano F. Bernengo MG: Mycosis fungoides in patients under 20 years of age: Report of 7 cases, review of the literature and study of the clinical course. Dermatology 1999;199:8-14.
24. Crowley JJ, Nikko A, Varghese A, Hoppe RT, Kim YH: Mycosis fungoides in young patients: Clinical characteristics and outcome. J Am Acad Dermatol 1998;38:696-701.
25. Koch SE, Zackheim HS, Williams ML, Fletcher V, LeBoit PE: Mycosis fungoides beginning in childhood and adolescence. J Am Acad Dermatol 1987;17:563-570.
26. Peters MS, Thibodeau SN, White JW, Winkelmann RK: Mycosis fungoides in children and adolescents. J Am Acad Dermatol 1990;22: 1011-1018.
27. Wilson AGM, Cotter FE, Lowe DG, Stansfeld AG, Kirby JD: Mycosis fungoides in childhood. An unusual presentation. J Am Acad Dermatol 1991;25:370-372.
28. Lorinez AL: Cutaneous T-cell lymphoma (mycosis fungoides). Lancet 1996;347:871-876.
29. McFadden N, Nyfors A, Tanum G, Granholt A, Helme P, Kavli G: Mycosis fungoides in Norway 1960-1980. Acta Derm Venereol Suppl 1983;109:1-13.
30. Rowden G, Lewis MG: Langerhans cells: Involvement in the pathogenesis of mycosis fungoides. Br J Dermatol 1976;95:665-672.
31. Tan RA, Butterworth CM, McLaughlin H, Malka S, Samman PD: Mycosis fungoides, a disease of antigen persistence. Br J Dermatol 1974;91:607-616.
32. Zucker-Franklin D, Coutavas EE, Rush MG, Zouzias C: Detection of human T-lymphotropic virus-like particles in cultures of peripheral blood lymphocytes from patients with MF. Proc Natl Acad Sci USA 1991;88:7630-7634.
33. Bazarbachi A, Soriano V, Pawson R, Vallejo A, Moudgil T, Matutes E, Peries J, Molina A, de The H, Schulz TF, Catovsky D, Gill PS: Mycosis fungoides and Sézary syndrome are not associated with HTLV-I infection: An international study. Br J Haematol 1997;98:927-933.
34. Manzari V, Gismondi A, Barillari G, Morrone S, Modesti A, Albonici L, De Marchis L, Fazio V, Gradilone A, Zani M, Frati L, Santoni AL: HTLV-V, a new human retrovirus isolated in a Tac-negative T-cell lymphoma/leukemia. Science 1987;238:1581-1583.
35. Burns MK, Cooper KD: Cutaneous T-cell lymphoma associated with HIV infection. J Am Acad Dermatol 1993;29:394-399.
36. Whittemore AS, Holly EA: Mycosis fungoides in relation to environmental exposures and immune response: A case-control study. J Natl Cancer Inst 1989;81:1560-1567.
37. Tuyp E, Burgoyne A, Aitchinson T, Mackie R: A case-control study of possible causative factors in mycosis fungoides. Arch Dcrmatol 1987;123:196-200.
38. Linet MS, McLaughlin JK, Malker MS, Chow WH: Occupation and hematopoietic and lymphoproliferative malignancies among women: A linked registry study. J Occup Med 1994;36: 1187-1198.
39. Zachariae H, Sogaard H: Plutonium-induced mycosis fungoides and parapsoriasis en plaques - A new entity? Curr Probl Dermatol 1990;19:81-89.
40. Weinstock MA: A registry-based case-control study of mycosis fungoides. Ann Epidemiol 1991;1:533-539.
41. Berkson J: Limitations of the application of fourfold table analysis to hospital data. Biometrics 1946;2:47.
42. Nahass GT, Kraffert CA: Cutaneous T-cell lymphoma associated with the acquired immunodeficiency syndrome. Arch Dermatol 1991; 127:1020-1022.
43. Kim YH, Bishop K, Varghese A. Hoppe RT: Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome. Arch Dermatol 1995;131:1003-1008.
44. Levi JA, Wiernick PH: Management of mycosis fungoides: Current status and future prospects. Medicine 1975;54:63.
45. Hoppe RT, Medeiros LJ, Warnke RA, Wood GS: CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol 1995;32:448-453.
46. Epstein EH Jr, Levin DL: Mycosis fungoides: Survival, prognostic features, response to therapy and autopsy findings. Medicine 1972:15: 61-72.